3,4-二溴-N-甲基马来酰亚胺，CAS 登记号 3005-27-4，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 3,4-二溴-N-甲基马来酰亚胺 的 CAS 号：3005-27-4，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
3,4-Dibromo-N-methylmaleimide · CAS 3005-27-4 · C5H3Br2NO2. UNII V5U5TK6UT5.
| CAS Registry Number | 3005-27-4 |
|---|---|
| PubChem CID | 18155 |
| Molecular formula | C5H3Br2NO2 |
| IUPAC name | 3,4-dibromo-1-methylpyrrole-2,5-dione |
| UNII (FDA) | V5U5TK6UT5 |
| Molecular Weight | 268.89 |
|---|---|
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 268.85100 |
| Monoisotopic Mass | 266.85305 |
| Topological Polar Surface Area | 37.4 |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (100%), H319 (97.5%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H319 (97.5%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
2,3-Dibromo-N-methylmaleimide; RefChem:441983; 625-814-9; 3005-27-4; N-Methyl-2,3-dibromomaleimide; 3,4-dibromo-1-methylpyrrole-2,5-dione; N-Methyl-dibromomaleinimide; MALEIMIDE, DIBROMO-N-METHYL-; 3,4-dibromo-1-methyl-2,5-dihydro-1H-pyrrole-2,5-dione; 3,4-Dibromo-1-methyl-1H-pyrrole-2,5-dione; 1H-Pyrrole-2,5-dione, 3,4-dibromo-1-methyl-; Maleimide, 2,3-dibromo-N-methyl-; MFCD00102284; NSC 120444; BRN 0129149; 3,4-Dibromo-N-methylmaleimide
CAS 3005-27-4; molecular formula C5H3Br2NO2; molecular weight — g/mol.
2,3-Dibromo-N-methylmaleimide, RefChem:441983, 625-814-9, 3005-27-4, N-Methyl-2,3-dibromomaleimide, 3,4-dibromo-1-methylpyrrole-2,5-dione.
Hazard statements reported: H302, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.